FAK-IN-24
FAK-IN-24 (Compound 9f) is a FAK inhibitor (IC50: 0.815 nM) . FAK-IN-24 induces DNA damage and apoptosis. FAK-IN-24 has anti-glioblastoma activity. FAK-IN-24 inhibits proliferation of glioblastoma cell lines U87-MG (IC50 = 15 nM) and U251 (IC50 = 20 nM) . FAK-IN-24 inhibits tumor growth in U87-MG xenograft model[1].
Product Specifications
CAS Number
3062175-62-3
UNSPSC
12352211
Target
Apoptosis; FAK
Related Pathways
Apoptosis; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
O=C(CCCC1=CC=C(N(CCCl)CCCl)C=C1)OCCN2CCN(CC2)C3=CC=C(NC4=NC=C(C(F)(F)F)C(NC5=C(C(NC)=O)C=CC=C5)=N4)C=C3
Molecular Formula
C39H45Cl2F3N8O3
Molecular Weight
801.73
References & Citations
[1]Wei Y, et al. Discovery of noncovalent diaminopyrimidine-based Inhibitors for glioblastoma via a dual FAK/DNA targeting strategy. Eur J Med Chem. 2025 Mar 15;286:117288.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC040745-500 1x 500 µL
CD45 / LCA (2B11 + PD7/26), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470848-500 1x 500 µL
CD31 / PECAM-1 (C31.10), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741124-500 1x 500 µL
TOX3 (TOX3/1124), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details